61 related articles for article (PubMed ID: 20736744)
1. The Value of Combined Detection of Serum PSA, MALAT1 and TMPRSS2-ETV1 in Evaluating the Progress and Prognosis of Prostate Cancer.
Zhao G; Pan Z; Wang P
Arch Esp Urol; 2023 Oct; 76(8):555-562. PubMed ID: 37960954
[TBL] [Abstract][Full Text] [Related]
2. Cascaded discrimination of normal, abnormal, and confounder classes in histopathology: Gleason grading of prostate cancer.
Doyle S; Feldman MD; Shih N; Tomaszewski J; Madabhushi A
BMC Bioinformatics; 2012 Oct; 13():282. PubMed ID: 23110677
[TBL] [Abstract][Full Text] [Related]
3. Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization.
Giner Moreno E; Quereda-Flores F; Hernández Chinchilla JA; Amigo Moreno R; Perez Ruiz MD; Carcelén López A; Rocher Benlloch J; Molió Sanchís P; Casares Calzada A; Marqués-Torrejón MÁ; Martínez-Cadenas C; Ruiz Cerdá JL; Loras Monfort A; Ramos Soler D
J Vis Exp; 2023 Nov; (201):. PubMed ID: 38047572
[TBL] [Abstract][Full Text] [Related]
4. High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases.
Brandi F; Grupp K; Hube-Magg C; Kluth M; Lang D; Minner S; Möller-Koop C; Graefen M; Heinzer H; Tsourlakis MC; Wittmer C; Jacobsen F; Huland H; Steurer S; Lebok P; Hinsch A; Wilczak W; Schlomm T; Simon R
Oncol Lett; 2018 Nov; 16(5):6238-6244. PubMed ID: 30333886
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific PTen deletion in mice activates inflammatory microRNA expression pathways in the epithelium early in hyperplasia development.
Dart DA; Uysal-Onganer P; Jiang WG
Oncogenesis; 2017 Dec; 6(12):400. PubMed ID: 29284790
[TBL] [Abstract][Full Text] [Related]
6. Expression of ERG Protein and TMRPSS2-ERG Fusion in Prostatic Carcinoma in Egyptian Patients.
Abdel-Hady A; El-Hindawi A; Hammam O; Khalil H; Diab S; El-Aziz SA; Badawy M; Ismail A; Helmy N; Kamel N; Anis S; Kholy AE; Osili KA; Abdel-Hady A; Nour H; Akl M
Open Access Maced J Med Sci; 2017 Apr; 5(2):147-154. PubMed ID: 28507619
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients.
Tsourlakis MC; Stender A; Quaas A; Kluth M; Wittmer C; Haese A; Graefen M; Steurer S; Simon R; Korbel J; Weischenfeldt J; Huland H; Sauter G; Schlomm T; Minner S
BMC Cancer; 2016 Aug; 16():641. PubMed ID: 27530104
[TBL] [Abstract][Full Text] [Related]
8. The oncogene ERG: a key factor in prostate cancer.
Adamo P; Ladomery MR
Oncogene; 2016 Jan; 35(4):403-14. PubMed ID: 25915839
[TBL] [Abstract][Full Text] [Related]
9. Clinically relevant genetic characterization of prostate tumors: how close are we to the goal?
Tolkach Y; Imkamp F; Godin K; Van Poppel H
Korean J Urol; 2015 Feb; 56(2):90-8. PubMed ID: 25685295
[TBL] [Abstract][Full Text] [Related]
10. Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy.
Morais CL; Han JS; Gordetsky J; Nagar MS; Anderson AE; Lee S; Hicks JL; Zhou M; Magi-Galluzzi C; Shah RB; Epstein JI; De Marzo AM; Lotan TL
Am J Surg Pathol; 2015 Feb; 39(2):169-78. PubMed ID: 25517949
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the TMPRSS2:ERG fusion for the detection of prostate cancer: a systematic review and meta-analysis.
Yao Y; Wang H; Li B; Tang Y
Tumour Biol; 2014 Mar; 35(3):2157-66. PubMed ID: 24142545
[TBL] [Abstract][Full Text] [Related]
12. A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancer.
Qu X; Randhawa G; Friedman C; O'Hara-Larrivee S; Kroeger K; Dumpit R; True L; Vakar-Lopez F; Porter C; Vessella R; Nelson P; Fang M
Cancer Genet; 2013; 206(1-2):1-11. PubMed ID: 23352841
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia.
Lotan TL; Gumuskaya B; Rahimi H; Hicks JL; Iwata T; Robinson BD; Epstein JI; De Marzo AM
Mod Pathol; 2013 Apr; 26(4):587-603. PubMed ID: 23222491
[TBL] [Abstract][Full Text] [Related]
14. Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies.
Tomlins SA; Palanisamy N; Siddiqui J; Chinnaiyan AM; Kunju LP
Arch Pathol Lab Med; 2012 Aug; 136(8):935-46. PubMed ID: 22849743
[TBL] [Abstract][Full Text] [Related]
15. The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis.
Pettersson A; Graff RE; Bauer SR; Pitt MJ; Lis RT; Stack EC; Martin NE; Kunz L; Penney KL; Ligon AH; Suppan C; Flavin R; Sesso HD; Rider JR; Sweeney C; Stampfer MJ; Fiorentino M; Kantoff PW; Sanda MG; Giovannucci EL; Ding EL; Loda M; Mucci LA
Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1497-509. PubMed ID: 22736790
[TBL] [Abstract][Full Text] [Related]
16. ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin.
Williamson SR; Zhang S; Yao JL; Huang J; Lopez-Beltran A; Shen S; Osunkoya AO; MacLennan GT; Montironi R; Cheng L
Mod Pathol; 2011 Aug; 24(8):1120-7. PubMed ID: 21499238
[TBL] [Abstract][Full Text] [Related]
17. Detection of TMPRSS2 gene deletions and translocations in carcinoma, intraepithelial neoplasia, and normal epithelium of the prostate by direct fluorescence in situ hybridization.
Zhang S; Pavlovitz B; Tull J; Wang Y; Deng FM; Fuller C
Diagn Mol Pathol; 2010 Sep; 19(3):151-6. PubMed ID: 20736744
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases.
Mehra R; Han B; Tomlins SA; Wang L; Menon A; Wasco MJ; Shen R; Montie JE; Chinnaiyan AM; Shah RB
Cancer Res; 2007 Sep; 67(17):7991-5. PubMed ID: 17804708
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer.
Winnes M; Lissbrant E; Damber JE; Stenman G
Oncol Rep; 2007 May; 17(5):1033-6. PubMed ID: 17390040
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
